XML 27 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF PREFERRED UNITS AND STOCKHOLDERS' EQUITY/MEMBERS' DEFICIT - USD ($)
$ in Thousands
Total
Pre-funded Warrant
IPO
ATM Equity Offering Program
Common Units
Incentive Units
Common Stock
Common Stock
Pre-funded Warrant
Common Stock
IPO
Common Stock
ATM Equity Offering Program
Additional Paid-in Capital
Additional Paid-in Capital
Pre-funded Warrant
Additional Paid-in Capital
IPO
Additional Paid-in Capital
ATM Equity Offering Program
Accumulated Deficit
Accumulated Other Comprehensive Income
Series A Preferred Units
Series B Preferred Units
Beginning balance at Dec. 31, 2022                                 $ 28,971 $ 148,496
Beginning balance (in shares) at Dec. 31, 2022                                 20,000,000 45,089,212
PREFERRED UNITS                                    
Conversion of preferred, common, and incentive units into common stock                                 $ (28,971) $ (148,496)
Conversion of preferred, common, and incentive units into common stock (in shares)                                 (20,000,000) (45,089,212)
Beginning balance at Dec. 31, 2022 $ (35,392)       $ 2,251 $ 2,142                 $ (39,785)      
Beginning balance (in shares) at Dec. 31, 2022         5,000,000 1,625,086                        
MEMBERS' DEFICIT                                    
Vesting of incentive units 0         922,338                        
Conversion of preferred, common, and incentive units into common stock $ 177,467       $ (2,251) $ (4,686)         $ 184,404              
Conversion of preferred, common, and incentive units into common stock (in shares)         (5,000,000) (2,547,424) 27,597,438                      
Common stock issued in IPO, net of issuance costs     $ 315,391                   $ 315,391          
Common stock issued in IPO, net of issuance costs (in shares)                 20,297,500                  
Vesting of restricted common stock (in shares)             443,831                      
Issuance of common stock upon exercise of stock options (in shares) 0         922,338                        
Equity-based compensation expense $ 6,103         $ 2,544         3,559              
Unrealized gains on marketable securities, net of tax 329                             $ 329    
Net loss (83,985)                           (83,985)      
Ending balance at Dec. 31, 2023 379,913                   503,354       (123,770) 329    
Ending balance (in shares) at Dec. 31, 2023             48,338,769                      
MEMBERS' DEFICIT                                    
Vesting of incentive units             43,025                      
Common stock issued in IPO, net of issuance costs 449,955     $ 43,528     $ 1       449,954     $ 43,528        
Common stock issued in IPO, net of issuance costs (in shares)             7,790,321     926,049                
Vesting of restricted common stock (in shares)             937,083                      
Issuance of common stock upon exercise of stock options 852                   852              
Issuance of common stock upon exercise of stock options (in shares)             43,025                      
Issuance of common stock under employee stock purchase plan 774                   774              
Issuance of common stock under employee stock purchase plan (in shares)             27,651                      
Equity-based compensation expense 23,332                   23,332              
Unrealized gains on marketable securities, net of tax 586                             586    
Net loss (182,146)                           (182,146)      
Ending balance at Dec. 31, 2024 $ 716,794           $ 1       1,021,794       (305,916) 915    
Ending balance (in shares) at Dec. 31, 2024             58,062,898                      
MEMBERS' DEFICIT                                    
Vesting of incentive units 222,104           222,104                      
Common stock issued in IPO, net of issuance costs       $ 65,582                   $ 65,582        
Common stock issued in IPO, net of issuance costs (in shares)                   1,175,701                
Common stock and pre-funded warrants issued (In Shares)               8,048,782                    
Common stock and pre-funded warrants issued   $ 324,052                   $ 324,052            
Vesting of restricted common stock (in shares)             850,110                      
Issuance of common stock upon exercise of stock options $ 5,300                   5,300              
Issuance of common stock upon exercise of stock options (in shares) 222,104           222,104                      
Issuance of common stock under employee stock purchase plan $ 1,556                   1,556              
Issuance of common stock under employee stock purchase plan (in shares)             41,754                      
Equity-based compensation expense 46,277                   46,277              
Unrealized gains on marketable securities, net of tax 165                             165    
Net loss (255,843)                           (255,843)      
Ending balance at Dec. 31, 2025 $ 903,883           $ 1       $ 1,464,561       $ (561,759) $ 1,080    
Ending balance (in shares) at Dec. 31, 2025             68,401,349